{"name":"Allaysis, LLC","slug":"allaysis-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AJBVV95cUxNVjVBVkdreVdyOG12cTk2cHJ3NDM1Tm9ueGhaa25xcnBaSW1seWFKRWlpX1EzQlVFeXdzS1lod19NRFFKQkIweXRPTnFSTEhRRWwydjZKdmRVazl2Mm5GNlVjSjBQMjRlZTNaRlcyMUdYZDBKXy1YRTFQN3hkeTNSV0k2QU14Z3ppWFNWazV1UlJYaTZHT3VWMURUSXhSbE5DNWYzVUpmNFdNMFB5ZzVNc21mcGo5TmJsVFh1WEZ6Z29KcnlZZmFZV2J4ejlZTXo3ZXNGYzBVRFJIUUs2dVlmWnEwSUx4NTJvMktHSEZfMDF2SEw3X0h6V25HMVZ2aDFJa0RNOVY4aVNZekZmZUEzd1ZIU1RQQXl2bU9VZ0dsMFpzSUdxM1hiNmNwZGJJRm9LaDBzTHNqNUdSLVNrdVBwSVNOd3lZTE8zR2kwNTBmU2dEbGdWWjRaMEtfakVleF9pRG8zaXUzVjd6RVFG?oc=5","date":"2026-02-19","type":"trial","source":"GlobeNewswire","summary":"Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophyla","headline":"Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-12","type":"pipeline","source":"simplywall.st","summary":"Analysts Expect Breakeven For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Before Long - simplywall.st","headline":"Analysts Expect Breakeven For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Before Long","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-13","type":"pipeline","source":"simplywall.st","summary":"Insufficient Growth At NATCO Pharma Limited (NSE:NATCOPHARM) Hampers Share Price - simplywall.st","headline":"Insufficient Growth At NATCO Pharma Limited (NSE:NATCOPHARM) Hampers Share Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNSUpOanNhMFQweksyc0dtcG9RUDlvTHZuczllWHRXTkxLZFpOckphOTdjd1g0ZFU2RUZKTUhQNXIxblJ2Z0UyLW1iS0ZUeWVEZ0JPeDNxOUJtN3dvTExMNVFFRjNhWWQ4SENPV3JnZXZJTloxTTBBd3hiWVhOMTltbC1nQWg5dm9ORnRQSnFIcXJPRGV0WGhPbw?oc=5","date":"2025-11-11","type":"pipeline","source":"Yahoo Finance","summary":"Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics - Yaho","headline":"Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQV0FlNU91eHUwZTl3QkZJbDRiRTFnVEllcjZIMXp0UGQ1SUlDdzNMUXJObHdrZm1QNkJObXN0X2RGd05FblJod2FZLVJZRkw4R0xPZUpNdnBud3o0V1ZzQUM2dlV4WnBlbVUtOWxWa0tTbVVWRWozam5rTkpfNjZFb3FGYTlNUE1maWtRMVBGemRiZm1ZckxjU2VndmtvM01ESUVzQQ?oc=5","date":"2025-09-01","type":"pipeline","source":"Grand View Research","summary":"Middle East Pharmaceutical Excipient Market Report, 2033 - Grand View Research","headline":"Middle East Pharmaceutical Excipient Market Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPbWwwLXdjdEhYQi12RkhwSWNLeFl0dzJpNW9NMDFXRkQtQ1ZQU0dlRjVvVzFtTUJ2aFRWV2VNZXdwQ1dqSUY0X3p4dkdScGM3TV9ETC13NmFzOTVYdXg2TGhpb1BoNGRHTGZJbDhXX1FVLU9XSzVPYkw2YkMyZmFQeFBCSlUydTRWa2RRQzRqdnRvb0VDS2JZMTlSeG1zT2kxb2w0?oc=5","date":"2025-08-20","type":"pipeline","source":"seekingalpha.com","summary":"Industry Analysis: Eli Lilly Stock Tops My Tier Two Pharmaceuticals List (NYSE:LLY) - seekingalpha.com","headline":"Industry Analysis: Eli Lilly Stock Tops My Tier Two Pharmaceuticals List (NYSE:LLY)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5Sc0I0dUhEcjI4cVFhVjBlWjdGN281YU9DN1NyTmc3X1pXbm94VmQ5SGxYaWp5NU5hSU5DY2J5bWJ6TTNpUFB5S2Rrc2MtVXkxd0JJRmpIQ3FFZjdreEszbHppYzlsc3RPUndPMm04WWE3S3BVcjZFT2tn?oc=5","date":"2025-05-06","type":"trial","source":"Patently-O","summary":"Clinical Trials Get a Legal Shield: Federal Circuit Reverses Pharma Patent Injunction - Patently-O","headline":"Clinical Trials Get a Legal Shield: Federal Circuit Reverses Pharma Patent Injunction - Patently","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9TSnB0NTBmdS1Wa2RrX1BqRjJNZ2dtUTNvZXEtaE96RTZVMmJkemcyZ09OX0tOWUZXdEI4emZuSlJFTFc5VU1ZUjZDMjFWeVBablFZ?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"PTPI Stock Price, News & Analysis - Stock Titan","headline":"PTPI Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQczA3WmxmZFZhVDR0aVlZWnNfbTNvT2Y2Z1JxZWNyQk9SanlKM25zN1pfb09MLUhzWEdpM1p6REtIMk9Zc1g0bGNPbnc4VXhsby1iWlM1d1BpT2pDeVQ2Ti1SR1VnZUNMZ0xIcGMtbU9UUTFrVjY4Qmw2dnp4bndZRUloX3pNM25oZG0yN1dzVVpZZFRKLVdPRlMyV05rRHR2dm9aNC02VkYzelU?oc=5","date":"2025-03-31","type":"pipeline","source":"Contract Pharma","summary":"Accelerating Sequence Variant Analysis in Biologic Drug Development - Contract Pharma","headline":"Accelerating Sequence Variant Analysis in Biologic Drug Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPblh6SWlTUmtFTExOZXdYQk5XUWJSd1lBTkpzZlR2d2JRRkgtWUFLRHZiNXFvb2xOY3RfMGZqQnNVbWJiYUp4cFFnVm9GM3ZvOU14enNNOGR5VGxqdkRBYWZteV9oNjZKaW5LV0s5dHc4NTdPVUtvZlg5SGRfanBYRGZyZno3Mk5lcVFDV0pJYXVEQXR5eXl4Qnh3RVBKU0JoZmpLZVN1cGNnNDIwZ19fQU9xSThDcTlZZlE?oc=5","date":"2025-03-12","type":"pipeline","source":"Fierce Pharma","summary":"Argenx's Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts - Fierce Pharma","headline":"Argenx's Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQdEVudzNuVVEwWXV6ZkpZbEp5SXEyTTBXaDJKMU81ZXlwaGdZdldTVXhTc3BqeEdiQkxudEhCVV9rSElFSy05WUtwM3k4ck1HdFhITXgyZm53cEJ5dTNCTm5VQWRockdWUlkyUTgwcmNLRU9PZTVTc19uNTBZdjRZVW1CV1ViQVNvdVFGbzE3WXJDMzBfbHk2UDdEN01La19VWnl6UkJ4STZlVjdodjBjODNSdzBqeWl1ME5LMms0MG1kU3VaSmZ1ak01Q3U4aDRGcUdhcDlDa2hPVjUwR1Z3QVNzd0dxRFlXa0ZnWHhTb0dRSWM0NVBKbEhiMGdDblZpTkF0Z2NtSl91eTlfajhoaWtpVm1WNmEyVVE?oc=5","date":"2022-11-26","type":"pipeline","source":"prnewswire.com","summary":"Cold Chain Logistics Market for Pharmaceuticals Industry: Historic Industry Size and Analysis of 15 Vendors and 7 Countries - Technavio - prnewswire.com","headline":"Cold Chain Logistics Market for Pharmaceuticals Industry: Historic Industry Size and Analysis of 15 Vendors and 7 Countr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQd19TZmpOOGNfOG1rNXdKc0VRV2ZfbVZNRExyVk0waHZHX3J5OFVqVXR2OHFSeDRsT3V0U2oyRGpYVGNFN1VxajVxWGRwQUdYQkFXQWpWYW43dU5jSnlTV1M2ZW5DN2kxVGNsZjRRNnh3OXhRN0FmcU5LcWJCejltLTJoVlZWdw?oc=5","date":"2020-02-12","type":"pipeline","source":"JD Supra","summary":"Federal Circuit Revolutionizes Country of Origin Analysis for Pharmaceuticals - JD Supra","headline":"Federal Circuit Revolutionizes Country of Origin Analysis for Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}